• Gatta G, Capocaccia R, De Angelis R, Stiller C, Coebergh JW and the EUROCARE Working Group. (2003) Cancer survival in European adolescents and young adults. European Journal of Cancer, 39, 2600-2610.
  • Gatta G, Corazziari I, Magnani C, Peris-Bonet R, Roazzi P, Stiller C and the EUROCARE Working Group. (2003) Childhood cancer survival in Europe. Ann Oncol, 14, v119-v127.
  • Satgé D, Moore SW, Stiller CA, Niggli FK, Pritchard-Jones K, Bown N, Bénard J & Plantaz D (2003) Abnormal constitutional karyotypes in patients with neuroblastoma: a report of four new observations and reviews of 47 other cases in the literature. Cancer Genet Cytogenet, 147, 89-98.
  • Guérin S, Dupuy A, Anderson H, Shamsaldin A, Svahn-Tapper G, Moller T, Quiniou E, Garwicz S, Hawkins M, Avril MF, Oberlin O, Chavaudra J & de Vathaire F (2003) Radiation dose as a risk factor for malignant melanoma following childhood cancer. European Journal of Cancer, 39, 2379-2386.
  • Sorahan T, Haylock RGE, Muirhead CR, Bunch KJ, Kinlen LJ, Little MP, Draper GJ, Kendall GM, Lancashire RJ & English MA (2003) Cancer in the offspring of radiation workers: an investigation of employment timing and a reanalysis using updated dose information. British Journal of Cancer, 89, 1215-1220.
  • Kardos G, Baumann I, Passmore SJ, Locatelli F, Hasle H, Schultz KR, Starý J, Schmitt-Graeff A, Fischer A, Harbott J, Chessells JM, Hann I, Fenu S, Rajnoldi AC, Kerndrup G, van Wering E, Rogge T, Nöllke P & Niemeyer CM (2003) Refractory anemia in childhood: a retrospective analysis of 67 patients with particular reference to monosomy 7. Blood, 102, 1997-2003.
  • Passmore SJ, Chessells JM, Kempski H, Hann IM, Brownbill PA & Stiller CA (2003) Paediatric myelodysplastic syndromes and juvenile myelomoncytic leukaemia in the UK: a population-based study of incidence and survival. British Journal of Haematology, 121, 758-767.
  • Honjo S, Doran HE, Stiller CA, Ajiki W, Tsukuma H, Oshima A & Coleman MP (2003) Neuroblastoma trends in Osaka, Japan, and Great Britain 1970-1994, in relation to screening. International Journal of Cancer, 103, 538-543.